Home›Search›Discover Oncology

Discover Oncology

Springer Science and Business Media Deutschland GmbH · Germany · Est. 2006

ISSN2730-6011eISSN2730-6011

SJR Q2✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

100

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (4 more)+22

Total100

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

157

days submission → published

measured · last 20 articles · accept 124d

weeks to publish · journal-reported

Fast · vs ~15 wk median

SJR Rank

Top 50% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2 · Scopus CiteScore 1.9. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.731

H-Indexi

CiteScorei

1.9

SNIPi

0.645

Total Worksi

4,419

Total Citationsi

11,962

2yr Mean Citednessi

1.77

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Discover Oncology is an open access journal publishing content that interfaces at all levels of cancer research. Covers basic and translational science, through to preclinical, clinical, and epidemiology.

General Information

Country / RegionGermany

Primary LanguageEnglish

1st Year Published2006

FrequencyAnnual

StatusActive (last: 2026)

Total Publications4,419

Publisher OrgSpringer Nature

OA Since2020

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

Review Time~5 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PorticoPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Springer Science and Business Media Deutschland GmbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2730-6011 / 2730-6011

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

Portico, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2012

2014

1.1k

2021

146

1.8k

2022

235

2.3k

2023

851

3.9k

2024

2.5k

5.3k

2025

1.1k

116

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2

Cancer ResearchQ3

Endocrine and Autonomic SystemsQ3

EndocrinologyQ3

Endocrinology, Diabetes and MetabolismQ3

Subject Classification

Web of Science Categories

Endocrinology & MetabolismOncology

Scopus Categories

Cancer ResearchEndocrine and Autonomic SystemsEndocrinology, Diabetes and MetabolismEndocrinologyOncology

Research Topics (OpenAlex)

Ferroptosis and cancer prognosisCancer Immunotherapy and BiomarkersCancer-related molecular mechanisms researchRNA modifications and cancerMicroRNA in disease regulationImmune cells in cancerCancer, Hypoxia, and MetabolismSingle-cell and spatial transcriptomicsCancer, Lipids, and MetabolismCircular RNAs in diseases

Frequently asked questions about Discover Oncology

Is Discover Oncology a predatory journal?

PubScope has no integrity flags on record for Discover Oncology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Discover Oncology?

Discover Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 1.9.

Is Discover Oncology indexed in Scopus and Web of Science?

Discover Oncology is indexed in Web of Science, Scopus, DOAJ.